Dabigatran (Pradaxa) has received FDA approval for prevention of deep vein thrombosis and pulmonary embolism in patients undergoing hip replacement surgery.
EarlySense has signed a co-marketing agreement with Herman Miller-Nemschoff to offer healthcare furniture pre-enabled to accept EarlySense contact-free sensor-based monitoring.
Pfizer Inc, the maker of Viagra and Lipitor, has struck a deal to buy Botox-maker Allergan Plc in a transaction valued at about $160 billion.
A new study that evaluated the effect of roflumilast on normal human bronchial epithelial cells exposed to cigarette smoke found that it can help lungs that have been damaged by smoking.
The FDA has cleared Mallinckrodt Pharma's INOmax DSIR Plus MRI device for delivery of INOmax (nitric oxide) for inhalation during MRI procedures.
Salter's new devices include neonatal nasal CPAP and oxygen securement devices, ET tubes with polyurethane thin cuffs, divided capnography cannulas, aerosol nebulizers and masks.
This year's recipients were: Aerogen, CareFusion, Dräger, Fisher & Paykel, Monaghan Medical Corp, and Philips.
Routine use of EtCO2 monitoring in the prehospital setting will allow providers to give better, more timely and more effective care, according to an article published by JEMS.com.
The FDA has approved the drug mepolizumab for treating asthma in patients 12 years and older, according to MedPage Today.
CareFusion has announced that its AirLife business line has fined an agreement with ResMed to distribute nasal high flow interface products from the company.
AstraZeneca Canada has announced that the COPD treatment system DUAKLIR GENUAIR is now available in Canada and through the Canadian public health system.
The Simplexa Flu A/B and RSV direct kit has received premarket notification clearance from the Food and Drug Administration for additional influenza and RSV strains.
OrPro Therapeutics, Inc, a cystic fibrosis treatment, has received a patent covering the drug’s capacity to improve the viscoelastic properties of mucus secretions.
According to Healio, Daiichi Sankyo has issued a voluntary recall for two of its vaccine products.
The APA video laryngoscope is a handheld, portable device to aid in tracheal intubation and is interchangeable with Macintosh and Difficult Airway Blades.
The MightySat, which can be paired with iOS or Android devices to report data, incorporates Masimo SET Measure-through Motion and Low Perfusion technology.
INOmax (nitric oxide) for inhalation has received regulatory approval in Australia and Japan for pulmonary hypertension in conjunction with heart surgery.
The EU's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion to expand the current therapeutic indication for Volibris in pulmonary arterial hypertension (PAH).
The FDA has announced that Sanofi US is voluntarily recalling its Auvi-Q epinephrine injection because patients may receive an inaccurate and inadequate dose.
The BSM-1700 was developed to address the heightened safety challenges of transporting at-risk patients between points of care in the hospital setting, according to Nihon Kohden.